{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:13:41Z","timestamp":1787912021172,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijid.2016.03.022","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T04:06:20Z","timestamp":1459310780000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review"],"prefix":"10.1016","volume":"46","author":[{"given":"Linda Beatrice","family":"Mlunde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Fokas","family":"Sunguya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie Kazeni Kilonzo","family":"Mbwambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omary Said","family":"Ubuguyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamine","family":"Jimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.03.022_bib0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/QAI.0b013e318050d260","article-title":"Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study","volume":"45","author":"Huo","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2016.03.022_bib0225","first-page":"372","article-title":"Methamphetamine use and sexual risk behaviour in Cape Town, South Africa: a review of data from 8 studies conducted between 2004 and 2007","volume":"14","author":"Parry","year":"2011","journal-title":"Afr J Psychiatry (Johannesbg)"},{"key":"10.1016\/j.ijid.2016.03.022_bib0230","unstructured":"UNODC. World Drug Report 2015. United Nations Office on Drugs and Crime, 2015. Available from: https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf. Accessed 28 November 2015."},{"key":"10.1016\/j.ijid.2016.03.022_bib0235","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.03.022_bib0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.03.022_bib0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.aids.0000196566.40702.28","article-title":"Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda","volume":"20","author":"Bunnell","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.03.022_bib0250","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.03.022_bib0255","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.2013.278328","article-title":"Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples","volume":"310","author":"Anglemyer","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2016.03.022_bib0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.03.022_bib0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.idc.2007.03.009","article-title":"Clinical care of the HIV-infected drug user","volume":"21","author":"Bruce","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijid.2016.03.022_bib0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Soc Care Community"},{"key":"10.1016\/j.ijid.2016.03.022_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000173733","article-title":"Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs","volume":"78","author":"Fried","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.ijid.2016.03.022_bib0280","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2893.2005.00548.x","article-title":"The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre","volume":"12","author":"Restrepo","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2016.03.022_bib0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2011.08.005","article-title":"The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature","volume":"23","author":"Islam","year":"2012","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ijid.2016.03.022_bib0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1468-1293.2003.00130.x","article-title":"Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users","volume":"4","author":"Clarke","year":"2003","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2016.03.022_bib0295","first-page":"23","article-title":"Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia","volume":"41","author":"Achmad","year":"2009","journal-title":"Acta Med Indones"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2016.03.022_bib0300","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/QAI.0b013e3181f9c10b","article-title":"Drug treatment as HIV prevention: a research update","volume":"55","author":"Metzger","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2016.03.022_bib0305","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.ijid.2016.03.022_bib0310","unstructured":"United Nations Office on Drugs and Crime. Opioid substitution treatment (Buprernophine). Available at: http:\/\/www.unodc.org\/documents\/southasia\/Trainingmanuals\/BUPRENORPHINE_Low_res_09-06-12.pdf. Accessed 2015 January 15."},{"key":"10.1016\/j.ijid.2016.03.022_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jsat.2006.07.008","article-title":"On-site medical care in methadone maintenance: associations with health care use and expenditures","volume":"32","author":"Gourevitch","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ijid.2016.03.022_bib0320","first-page":"492","article-title":"Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program","volume":"108","author":"Selwyn","year":"1993","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ijid.2016.03.022_bib0325","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2105\/AJPH.84.2.207","article-title":"Providing medical care to methadone clinic patients: referral vs on-site care","volume":"84","author":"Umbricht-Schneiter","year":"1994","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ijid.2016.03.022_bib0330","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/S0140-6736(04)17490-4","article-title":"Opioid substitution and HIV\/AIDS treatment and prevention","volume":"364","author":"Kerr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.03.022_bib0335","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.aids.0000168982.20456.eb","article-title":"Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users","volume":"19","author":"Wood","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.03.022_bib0340","unstructured":"Centers for Disease Control and Prevention. Methadone Maintenance Treatment. Available at: http:\/\/www.cdc.gov\/idu\/facts\/MethadoneFin.pdf. Accessed 2015 January 20."},{"key":"10.1016\/j.ijid.2016.03.022_bib0345","unstructured":"World Health Organization. Lexicon of alcohol and drug terms published by the World Health Organization, 2006. Available at: http:\/\/www.who.int\/substance_abuse\/terminology\/who_lexicon\/en\/. Accessed: 2015 January 20."},{"key":"10.1016\/j.ijid.2016.03.022_bib0350","unstructured":"Mlunde L, Sunguya B, Mbwambo J, Yasuoka J, Ubuguyu O, Masamine J. Effectiveness of needle exchange programs and opioid substitution therapy on access to health care among people who inject drugs. 2014. Available at: http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42014009118. Accessed: 2015 January 26."},{"key":"10.1016\/j.ijid.2016.03.022_bib0355","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijid.2016.03.022_bib0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1468-1293.2009.00701.x","article-title":"Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study","volume":"10","author":"Weber","year":"2009","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2016.03.022_bib0365","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2016.03.022_bib0370","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2016.03.022_bib0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)80010-1","article-title":"Drug abuse, methadone treatment, and health services use among injection drug users with AIDS","volume":"60","author":"Sambamoorthi","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ijid.2016.03.022_bib0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2013.09.020","article-title":"Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine","volume":"134","author":"Bachireddy","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ijid.2016.03.022_bib0385","unstructured":"Cochrane Informatics and Knowledge Management Department. Available at: http:\/\/tech.cochrane.org\/revman. Accessed: 2014 December 20."},{"key":"10.1016\/j.ijid.2016.03.022_bib0390","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijid.2016.03.022_bib0395","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijid.2016.03.022_bib0400","unstructured":"Guideline Development Tool. Available at: http:\/\/gdt.guidelinedevelopment.org. Accessed: 2014 December 20."},{"key":"10.1016\/j.ijid.2016.03.022_bib0405","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/aje\/kwg209","article-title":"Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants","volume":"158","author":"Galai","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2016.03.022_bib0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000088581","article-title":"Drugs and social exclusion in ten European cities","volume":"12","author":"March","year":"2006","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.ijid.2016.03.022_bib0415","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2016.03.022_bib0420","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drugpo.2006.12.011","article-title":"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications","volume":"18","author":"Bruce","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ijid.2016.03.022_bib0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jsat.2010.05.001","article-title":"Methadone use among HIV-positive injection drug users in a Canadian setting","volume":"39","author":"Pettes","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ijid.2016.03.022_bib0430","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1300\/J069v19n01_07","article-title":"Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance","volume":"19","author":"Stein","year":"2000","journal-title":"J Addict Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216310098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216310098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T23:21:05Z","timestamp":1536880865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216310098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":43,"alternative-id":["S1201971216310098"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.03.022","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}